107. Juvenile idiopathic arthritis Clinical trials / Disease details


Clinical trials : 441 Drugs : 282 - (DrugBank : 56) / Drug target genes : 52 - Drug target pathways : 142

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01550003
(ClinicalTrials.gov)
March 8, 20127/3/2012Pediatric Arthritis Study of Certolizumab PegolA Multicenter, Open-label Study to Assess the Pharmacokinetics, Safety and Efficacy of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Polyarticular-course Juvenile Idiopathic Arthritis (JIA)Polyarticular-course Juvenile Idiopathic Arthritis (JIA)Drug: Certolizumab Pegol (CZP)UCB BIOSCIENCES GmbHPRA Health SciencesRecruiting2 Years17 YearsAll193Phase 3United States;Argentina;Brazil;Canada;Chile;Mexico;Russian Federation